Healthcare provider profile · identity verified

Jeremy T Goodwin, MD

Allopathic & Osteopathic Physicians|Internal Medicine · FORSYTH, GA · NPI 1639384407

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jeremy T Goodwin, MD received $63.80 in general payments during 2025 across 3 reported records.

Novo Nordisk Inc accounted for 70.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 254 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 125 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 79 claims for Trulicity by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 272 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$63.80

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$44.81	70.2%	2	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$18.99	29.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$63.80	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$26.65	1	2025
Source payment records 2025-02-05 · Novo Nordisk Inc · $26.65 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$26.65	1	2025
Source payment records 2025-02-05 · Novo Nordisk Inc · $26.65 · Open Payments source
KISUNLA Normalized: kisunla	Drug	Lilly USA, LLC	$18.99	1	2025
Source payment records 2025-09-03 · Lilly USA, LLC · $18.99 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	272	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	254	39
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	125	22
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	79	12
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	272	43

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1951	229
Amlodipine Besylate	Amlodipine Besylate	1796	204
Gabapentin	Gabapentin	1686	120
Pravastatin Sodium	Pravastatin Sodium	1531	80
Omeprazole	Omeprazole	1455	134
Levothyroxine Sodium	Levothyroxine Sodium	1272	121
Furosemide	Furosemide	1094	98
Lisinopril	Lisinopril	1051	99
Famotidine	Famotidine	946	48
Trazodone Hcl	Trazodone Hcl	892	82
Donepezil Hcl	Donepezil Hcl	867	37
Eliquis	Apixaban	850	77
Memantine Hcl	Memantine Hcl	814	33
Tamsulosin Hcl	Tamsulosin Hcl	793	70
Escitalopram Oxalate	Escitalopram Oxalate	788	79
Carvedilol	Carvedilol	770	73
Metoprolol Tartrate	Metoprolol Tartrate	741	51
Mirtazapine	Mirtazapine	728	58
Potassium Chloride	Potassium Chloride	727	75
Metoprolol Succinate	Metoprolol Succinate	696	72
Clopidogrel	Clopidogrel Bisulfate	659	52
Sertraline Hcl	Sertraline Hcl	604	58
Metformin Hcl	Metformin Hcl	593	109
Valsartan	Valsartan	592	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	573	97
Pantoprazole Sodium	Pantoprazole Sodium	544	87
Rosuvastatin Calcium	Rosuvastatin Calcium	521	131
Hydrochlorothiazide	Hydrochlorothiazide	469	92
Divalproex Sodium	Divalproex Sodium	439	16
Alprazolam	Alprazolam	431	93
Levetiracetam	Levetiracetam	429	24
Quetiapine Fumarate	Quetiapine Fumarate	405	27
Duloxetine Hcl	Duloxetine Hcl	368	34
Finasteride	Finasteride	366	19
Tramadol Hcl	Tramadol Hcl	339	82
Hydralazine Hcl	Hydralazine Hcl	310	22
Losartan Potassium	Losartan Potassium	308	68
Montelukast Sodium	Montelukast Sodium	290	40
Buspirone Hcl	Buspirone Hcl	285	23
Ozempic	Semaglutide	272	43
Bupropion Xl	Bupropion Hcl	264	26
Jardiance	Empagliflozin	254	39
Baclofen	Baclofen	219	11
Allopurinol	Allopurinol	217	36
Fluoxetine Hcl	Fluoxetine Hcl	216	16
Simvastatin	Simvastatin	213	55
Spironolactone	Spironolactone	204	25
Prednisone	Prednisone	197	95
Amiodarone Hcl	Amiodarone Hcl	181	18
Amitriptyline Hcl	Amitriptyline Hcl	175	19
Nifedipine Er	Nifedipine	173	suppressed
Xarelto	Rivaroxaban	170	12
Farxiga	Dapagliflozin Propanediol	156	32
Zolpidem Tartrate	Zolpidem Tartrate	152	35
Oxybutynin Chloride Er	Oxybutynin Chloride	147	13
Risperidone	Risperidone	141	suppressed
Sucralfate	Sucralfate	139	14
Meloxicam	Meloxicam	136	20
Entresto	Sacubitril/Valsartan	135	14
Clonazepam	Clonazepam	133	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	133	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	133	25
Fluticasone Propionate	Fluticasone Propionate	132	45
Albuterol Sulfate Hfa	Albuterol Sulfate	126	39
Glimepiride	Glimepiride	125	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	125	suppressed
Mounjaro	Tirzepatide	125	22
Olanzapine	Olanzapine	122	suppressed
Citalopram Hbr	Citalopram Hydrobromide	118	12
Hydrocortisone	Hydrocortisone	118	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	118	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	115	29
Diclofenac Sodium	Diclofenac Sodium	109	45
Shingrix	Varicella-Zoster Ge/As01b/Pf	108	94
Venlafaxine Hcl Er	Venlafaxine Hcl	107	15
Ondansetron Hcl	Ondansetron Hcl	106	37
Ropinirole Hcl	Ropinirole Hcl	106	13
Midodrine Hcl	Midodrine Hcl	104	12
Alendronate Sodium	Alendronate Sodium	100	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	100	suppressed
Lorazepam	Lorazepam	97	17
Carbidopa-Levodopa	Carbidopa/Levodopa	94	suppressed
Myrbetriq	Mirabegron	94	suppressed
Tizanidine Hcl	Tizanidine Hcl	94	40
Irbesartan	Irbesartan	86	22
Pioglitazone Hcl	Pioglitazone Hcl	86	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	23
Calcitriol	Calcitriol	84	suppressed
Celecoxib	Celecoxib	83	15
Oxybutynin Chloride	Oxybutynin Chloride	83	suppressed
Fluconazole	Fluconazole	82	22
Atenolol	Atenolol	79	suppressed
Trulicity	Dulaglutide	79	12
Doxazosin Mesylate	Doxazosin Mesylate	76	suppressed
Lamotrigine	Lamotrigine	76	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	23
Ezetimibe	Ezetimibe	72	15
Pregabalin	Pregabalin	72	14
Aripiprazole	Aripiprazole	71	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	70	68
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	19
Venlafaxine Hcl	Venlafaxine Hcl	66	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	41
Fenofibrate	Fenofibrate	64	11
Prazosin Hcl	Prazosin Hcl	64	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	64	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	14
Terazosin Hcl	Terazosin Hcl	61	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	60	13
Levemir Flexpen	Insulin Detemir	59	suppressed
Bupropion Hcl	Bupropion Hcl	58	suppressed
Latanoprost	Latanoprost	58	suppressed
Synthroid	Levothyroxine Sodium	58	suppressed
Methylprednisolone	Methylprednisolone	55	47
Torsemide	Torsemide	55	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	53	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	53	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	53	11
Telmisartan	Telmisartan	53	12
Topiramate	Topiramate	53	suppressed
Azithromycin	Azithromycin	52	30
Sevelamer Carbonate	Sevelamer Carbonate	52	suppressed
Tiagabine Hcl	Tiagabine Hcl	52	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	51	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	42
Bicalutamide	Bicalutamide	49	suppressed
Ibuprofen	Ibuprofen	49	13
Propranolol Hcl Er	Propranolol Hcl	48	suppressed
Bupropion Hcl Sr	Bupropion Hcl	47	suppressed
Letrozole	Letrozole	47	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	47	suppressed
Nystatin	Nystatin	45	21
Fenofibrate	Fenofibrate Nanocrystallized	43	13
Tresiba Flextouch U-100	Insulin Degludec	43	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	42	suppressed
Ipratropium Bromide	Ipratropium Bromide	41	11
Zonisamide	Zonisamide	41	suppressed
Estradiol	Estradiol	39	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	39	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	30
Benazepril Hcl	Benazepril Hcl	37	suppressed
Glipizide	Glipizide	37	suppressed
Metformin Hcl Er	Metformin Hcl	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Meclizine Hcl	Meclizine Hcl	36	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	36	suppressed
Levemir	Insulin Detemir	35	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	20
Ondansetron Odt	Ondansetron	34	14
Promethazine Hcl	Promethazine Hcl	34	15
Verapamil Er	Verapamil Hcl	34	16
Enalapril Maleate	Enalapril Maleate	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Propranolol Hcl	Propranolol Hcl	32	suppressed
Renvela	Sevelamer Carbonate	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Levofloxacin	Levofloxacin	31	24
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	30	29
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Digoxin	Digoxin	27	suppressed
Lactulose	Lactulose	27	12
Linzess	Linaclotide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Cefuroxime	Cefuroxime Axetil	26	17
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ursodiol	Ursodiol	26	suppressed
Diazepam	Diazepam	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	16
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Lacosamide	Lacosamide	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	19
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	25	suppressed
Amoxicillin	Amoxicillin	24	19
Azelastine Hcl	Azelastine Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Admelog Solostar	Insulin Lispro	23	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Insulin Aspart Flexpen	Insulin Aspart	23	suppressed
Lubiprostone	Lubiprostone	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Movantik	Naloxegol Oxalate	22	suppressed
Naproxen	Naproxen	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Invokana	Canagliflozin	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Primidone	Primidone	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Valproic Acid	Valproic Acid	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Vraylar	Cariprazine Hcl	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Colchicine	Colchicine	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	16	suppressed
Dofetilide	Dofetilide	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Potassium Citrate Er	Potassium Citrate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Hydroxyurea	Hydroxyurea	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Budesonide	Budesonide	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Cefdinir	Cefdinir	12	12
Klor-Con M20	Potassium Chloride	12	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	12	suppressed
Ramipril	Ramipril	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	12	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Donepezil Hcl Odt	Donepezil Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	11
Verapamil Sr	Verapamil Hcl	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$63.80 · 3 records	Novo Nordisk Inc	KISUNLA, Ozempic, Rybelsus	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error